Teladoc Health (TDOC) FCF Margin (2014 - 2026)

Teladoc Health has disclosed FCF Margin across 13 years of filings, most recently posting 4.02% for Q1 2026.

• FCF Margin for Q1 2026 came in at 4.02%, down 611.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.49% (down 581.0% YoY), and the FY2025 annual result was 6.95%, down 406.0% from the prior year.
• FCF Margin came in at 4.02% for Q1 2026 at Teladoc Health, down from 3.82% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 26.27% in Q3 2023 to a low of 12.62% in Q4 2022.
• The 5-year median for FCF Margin is 8.47% (2022), against an average of 7.34%.
• Across the five-year window, FCF Margin soared 3210 bps in 2023 and slumped 2956 bps in 2025, its largest moves.
• Teladoc Health's FCF Margin stood at 12.62% in 2022, then soared by 254 bps to 19.48% in 2023, then jumped by 32 bps to 25.74% in 2024, then plunged by 115 bps to 3.82% in 2025, then retreated by 5 bps to 4.02% in 2026.
• The last three FCF Margin figures came in at 4.02% (Q1 2026), 3.82% (Q4 2025), and 15.48% (Q3 2025), per Business Quant data.